Skip to content
healthcare.dev

ZYNRELEF

NDC 47426-503, BUPIVACAINE and MELOXICAM, solution, from Heron Therapeutics, Inc..

Product NDC
47426-503
Status
Listed
Labeler
Heron Therapeutics, Inc.
Dosage form
SOLUTION
Route
INFILTRATION
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA211988
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/47426-503 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPIVACAINE200 mg/7mL
  • MELOXICAM6 mg/7mL

Pharmacologic classes

Amide Local Anesthetic [EPC]; Amides [CS]; Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Local Anesthesia [PE]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
47426-503-01474260503011 CARTON in 1 KIT (47426-503-01) / 1 VIAL, SINGLE-DOSE in 1 CARTON (47426-503-03) / 2.3 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/dab484a7-9353-43ba-9e74-7fab910c712b

Use it

Look up 47426-503 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/47426-503 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 47426-503. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.